Literature DB >> 20546874

Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma.

Toby N Weingarten1, Juan P Cata, Jerome F O'Hara, David J Prybilla, Tasha L Pike, Geoffrey B Thompson, Clive S Grant, David O Warner, Emmanuel Bravo, Juraj Sprung.   

Abstract

OBJECTIVES: To compare the intraoperative and postoperative course of patients undergoing laparoscopic pheochromocytoma resection at 2 institutions (Mayo Clinic and Cleveland Clinic) with differing approaches to preoperative preparation. Patients undergoing adrenalectomy for pheochromocytoma typically undergo a preoperative preparation to normalize their blood pressure and intravascular volume. However, no consensus has been reached regarding the best preoperative preparation regimen.
METHODS: A retrospective chart review was performed of 50 Mayo Clinic patients and 37 Cleveland Clinic patients who had undergone laparoscopic pheochromocytoma resection. Mayo Clinic predominantly used the long-lasting nonselective alpha(1,2) antagonist phenoxybenzamine, and Cleveland Clinic predominately used selective alpha(1) blockade. Data regarding the intraoperative hemodynamics and postoperative complications were collected.
RESULTS: Almost all patients at Mayo Clinic received phenoxybenzamine (98%). At Cleveland Clinic, the predominant treatment (65%) was selective alpha(1) blockade (doxazosin, terazosin, or prazosin). Intraoperatively, patients at Cleveland Clinic had a greater maximal systolic blood pressure (209 +/- 44 mm Hg versus 187 +/- 30 mm Hg, P = .011) and had received a greater amount of intravenous crystalloid (median 5000, interquartile range 3400-6400, versus median 2977, interquartile range 2000-3139; P <.010) and colloid (median 1000, interquartile range 500-1000, versus median 0, interquartile range 0-0; P <.001). At Mayo Clinic, more patients had received phenylephrine (56.0% versus 27.0%, P = .009). No differences were found in the postoperative surgical outcomes, and the hospital stay was comparable between the 2 groups.
CONCLUSIONS: Differences in the preoperative preparation and intraoperative management were associated with differences in intraoperative hemodynamics but not with clinically significant outcomes in patients undergoing laparoscopic adrenalectomy for pheochromocytoma at 2 large tertiary care centers. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20546874     DOI: 10.1016/j.urology.2010.03.032

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  35 in total

1.  Robot assisted adrenalectomy: a handy tool or glorified obsession?

Authors:  Mrinal Pahwa
Journal:  Gland Surg       Date:  2015-08

2.  Improvement of preoperative management in patients with adrenal pheochromocytoma.

Authors:  Jiang Li; Chang-Hai Yang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  [Anesthetic management during pheochromocytoma surgery : Current strategies].

Authors:  B J Nottebaum; H Groeben
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

4.  Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients.

Authors:  Laurent Brunaud; Phi-Linh Nguyen-Thi; Eric Mirallie; Marco Raffaelli; Menno Vriens; Pierre-Etienne Theveniaud; Myriam Boutami; Brendan M Finnerty; Wessel M C M Vorselaars; Inne Borel Rinkes; Rocco Bellantone; Celestino Lombardi; Thomas Fahey; Rasa Zarnegar; Laurent Bresler
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

5.  Laparoscopic transperitoneal anterior adrenalectomy in pheochromocytoma: experience in 62 patients.

Authors:  Alessandro M Paganini; Andrea Balla; Mario Guerrieri; Giovanni Lezoche; Roberto Campagnacci; Giancarlo D'Ambrosio; Silvia Quaresima; Maria Vittoria Antonica; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2014-04-16       Impact factor: 4.584

Review 6.  [Preoperative α-receptor block in patients with pheochromocytoma? Against].

Authors:  H Groeben
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

7.  Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method.

Authors:  Nils Habbe; Florian Ruger; Jorg Bojunga; Wolf Otto Bechstein; Katharina Holzer
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

8.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

9.  Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.

Authors:  Reese W Randle; Courtney J Balentine; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2016-08-25       Impact factor: 5.344

10.  Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.

Authors:  Ritesh Agrawal; Saroj Kanta Mishra; Eesh Bhatia; Anjali Mishra; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.